Targeting regulatory T cells with Interleukin-2 treatment in type 1 diabetes: a response-adaptive, non-randomised, open-label trial of repeat doses of Aldesleukin (DILfrequency)
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Jane Kennet Linda S Wicker Mark L. Evans Frank D Waldron-Lynch Neil M Walker Katerina Anselmiova John A. Todd Linsey Porter |
| Publication date | November 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |